Emma S. Tomlinson Guns

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

33h-index4.6kcitations151works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(62), Estrogen and related hormone effects(34), Cancer, Lipids, and Metabolism(21), Extracellular vesicles in disease(13), Hormonal and reproductive studies(13)

Publications151 total

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells
Endocrine Related Cancer·2023· 3 citedOpen Access
Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective
Cancer Chemotherapy and Pharmacology·2023· 6 cited
Supplementary Figure Legends from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 3 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 3 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 2 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 2 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 6 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 6 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 5 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 4 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Data from GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression
2023Open Access
Data from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Data from GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression
2023Open Access
Data from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Data from GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression
2023Open Access
Data from GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression
2023Open Access
Supplementary Figure 5 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure 1 from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figure Legends from Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Hans Adomat(25), Martin Gleave(7), Mei Yieng Chin(6), Subrata Deb(6), Colleen C. Nelson(5), Elham Hosseini‐Beheshti(5), Paul S. Rennie(5), Michael Cox(5), Ladan Fazli(5), Jennifer A. Locke(4), Geetanjali Kharmate(4), Kishor M. Wasan(4), Andy Eberding(4), Steven Pham(3), Lawrence D. Mayer(3), Mani Roshan‐Moniri(3), Eric Leblanc(3), Artem Cherkasov(3), Gerald Krystal(3), Jacob A. Gordon(3)